Search results
Executive Leadership Team. Members of the Executive Leadership team report directly to MD Anderson’s president. Peter Pisters, M.D. President.
Sep 27, 2024 · MD Anderson’s commitment to end cancer doesn’t stop at home. Kathleen Schmeler, M.D., associate vice president of Global Oncology, discusses our work in Zambia and beyond as we focus on improving cancer prevention and care around the globe.
Oct 21, 2019 · As chief operating officer, Rosanna Morris oversees both the strategic and day-to-day performance of MD Anderson’s clinical administration to ensure we provide high quality care for our cancer patients.
The mouse care and handling procedures were approved by the Institutional Animal Care and Use Committee of The University of Texas MD Anderson Cancer Center. The orthotopic GBM brain tumor models were generated by mixing tumor cells (GL261, DBT, or CT2A) with an equal volume of 3% methylcellulose in phosphate-buffered saline (PBS) solution.
Nodular lymphocyte–predominant Hodgkin lymphoma (HL) usually presents in early stages. Therapy depends on disease extent, but localized radiotherapy is the usual choice for early-stage disease. Rituximab is also an effective agent, but it should be given in combination with chemotherapy.
Sep 19, 2024 · Dr. Katz is Professor and Chair of the department of Surgical Oncology, and holds the Lockton Distinguished Chair in Pancreatic Cancer Research. An international leader in the treatment of pancreatic and periampullary malignancies, he has led two... Read More. Meet Matthew Katz, M.D.
A summary of interest in pursuing an administrative fellowship at MD Anderson, including both short- and long-term goals. The statement of interest should be no longer than one page or 700 words single spaced.
